Janssen's migraine drug wins expanded FDA approval

03/31/2014 | Healio (free registration)

Janssen Pharmaceuticals obtained the FDA's approval to market Topamax, or topiramate, for the prevention of migraine in adolescents 12 to 17. Topamax is the first FDA-approved drug for this indication in this age group. The drug was previously approved for treatment of seizure and migraine prevention in adults.

View Full Article in:

Healio (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT